| Phase A | Phase B |
---|
Study | Patient | Clonotype | Clonotype with | Clonotype with |
---|
 | (only diagnosis samples) | identified | frequency >100 | VDJ homology >80% |
---|
Pilot 1
| A | 1616 | 12 | 7 |
 | B | 1703 | 59 | 33 |
 | C | 2149 | 72 | 44 |
 | D | 870 | 10 | 5 |
 | E | 1398 | 35 | 21 |
 |
Average value
|
1547
|
38
|
22
|
Pilot 2
| A | 96 | 18 | 6 |
 | B | 278 | 72 | 11 |
 | E | 77 | 5 | 0 |
 |
Average value
|
150
|
32
|
6
|
- For each patient of both Pilot studies the total number of identified clonotypes (third column) is reported. The number of clonotypes with a frequency greater than 100 were selected and passed the Phase A are reported in fourth column. Then from the Phase A, clonotypes with a VDJ homology greater than 80% were selected and passed the Phase B (fifth column). The average value are reported in bold